145 related articles for article (PubMed ID: 27399885)
1. Synthesis and SAR studies of potent H(+)/K(+)-ATPase inhibitors of quinazolinone-Schiff's base analogues.
Rakesh KP; Shantharam CS; Manukumar HM
Bioorg Chem; 2016 Oct; 68():1-8. PubMed ID: 27399885
[TBL] [Abstract][Full Text] [Related]
2. Schiff's bases of quinazolinone derivatives: Synthesis and SAR studies of a novel series of potential anti-inflammatory and antioxidants.
Rakesh KP; Manukumar HM; Gowda DC
Bioorg Med Chem Lett; 2015 Mar; 25(5):1072-7. PubMed ID: 25638040
[TBL] [Abstract][Full Text] [Related]
3. Amino acids conjugated quinazolinone-Schiff's bases as potential antimicrobial agents: Synthesis, SAR and molecular docking studies.
Rakesh KP; Kumara HK; Ullas BJ; Shivakumara J; Channe Gowda D
Bioorg Chem; 2019 Sep; 90():103093. PubMed ID: 31288137
[TBL] [Abstract][Full Text] [Related]
4. Anticancer and DNA binding studies of potential amino acids based quinazolinone analogs: Synthesis, SAR and molecular docking.
Rakesh KP; Kumara HK; Manukumar HM; Channe Gowda D
Bioorg Chem; 2019 Jun; 87():252-264. PubMed ID: 30908968
[TBL] [Abstract][Full Text] [Related]
5. Multi-targeted dihydrazones as potent biotherapeutics.
Li C; Sridhara MB; Rakesh KP; Vivek HK; Manukumar HM; Shantharam CS; Qin HL
Bioorg Chem; 2018 Dec; 81():389-395. PubMed ID: 30199841
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Antiproliferative, and Antioxidant Evaluation of 2-Pentylquinazolin-4(3
El-Sayed AA; Ismail MF; Amr AEE; Naglah AM
Molecules; 2019 Oct; 24(20):. PubMed ID: 31640238
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of benzo[
Wang SM; Zha GF; Rakesh KP; Darshini N; Shubhavathi T; Vivek HK; Mallesha N; Qin HL
Medchemcomm; 2017 Jun; 8(6):1173-1189. PubMed ID: 30108827
[TBL] [Abstract][Full Text] [Related]
8. tert-Butyl 1,5-bis(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)-1,5-dioxopentan-2-ylcarbamate urea/thiourea derivatives as potent H+/K(+)-ATPase inhibitors.
Sharma A; Suhas R; Chandana KV; Banu SH; Channe Gowda D
Bioorg Med Chem Lett; 2013 Jul; 23(14):4096-8. PubMed ID: 23756367
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and antibacterial activity of novel Schiff base derivatives of quinazolin-4(3H)-one.
Wang X; Yin J; Shi L; Zhang G; Song B
Eur J Med Chem; 2014 Apr; 77():65-74. PubMed ID: 24607590
[TBL] [Abstract][Full Text] [Related]
10. Rational design of conformationally restricted quinazolinone inhibitors of poly(ADP-ribose)polymerase.
Hattori K; Kido Y; Yamamoto H; Ishida J; Iwashita A; Mihara K
Bioorg Med Chem Lett; 2007 Oct; 17(20):5577-81. PubMed ID: 17804225
[TBL] [Abstract][Full Text] [Related]
11. Molecular docking studies and biological evaluation of 1,3,4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors.
Tang J; Liu J; Wu F
Bioorg Chem; 2016 Dec; 69():29-36. PubMed ID: 27669118
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of some novel quinazolin-4(3H)-one hybrid molecules as potent urease inhibitors.
Menteşe E; Akyüz G; Yılmaz F; Baltaş N; Emirik M
Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800182. PubMed ID: 30375666
[TBL] [Abstract][Full Text] [Related]
13. Quinazoline-4(3H)-one derivatives as novel and potent inhibitors of soluble epoxide hydrolase: Design, synthesis and biological evaluation.
Hejazi L; Rezaee E; Tabatabai SA
Bioorg Chem; 2020 Jun; 99():103736. PubMed ID: 32229350
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, molecular docking, and some metabolic enzyme inhibition properties of novel quinazolinone derivatives.
Tokalı FS; Taslimi P; Demircioğlu İH; Karaman M; Gültekin MS; Şendil K; Gülçin İ
Arch Pharm (Weinheim); 2021 May; 354(5):e2000455. PubMed ID: 33537994
[TBL] [Abstract][Full Text] [Related]
15. Diorganotin(IV) complexes of biologically potent 4(3H)-quinazolinone derived Schiff bases: synthesis, spectroscopic characterization, DNA interaction studies and antimicrobial activity.
Prasad KS; Kumar LS; Chandan S; Jayalakshmi B; Revanasiddappa HD
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Oct; 81(1):276-82. PubMed ID: 21741298
[TBL] [Abstract][Full Text] [Related]
16. Development of α-glucosidase inhibitors by room temperature C-C cross couplings of quinazolinones.
Garlapati R; Pottabathini N; Gurram V; Kasani KS; Gundla R; Thulluri C; Machiraju PK; Chaudhary AB; Addepally U; Dayam R; Chunduri VR; Patro B
Org Biomol Chem; 2013 Aug; 11(29):4778-91. PubMed ID: 23778751
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Spectroscopic Properties and Antioxidant Activity of Bis-Hydrazones and Schiff's bases Derived from Terephthalic Dihydrazide.
Jois HS; Kalluraya B; Vishwanath T
J Fluoresc; 2015 May; 25(3):481-8. PubMed ID: 25820870
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase.
Lu W; Baig IA; Sun HJ; Cui CJ; Guo R; Jung IP; Wang D; Dong M; Yoon MY; Wang JG
Eur J Med Chem; 2015 Apr; 94():298-305. PubMed ID: 25771108
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological assay in vitro and molecular docking studies of new Schiff base derivatives as potential urease inhibitors.
Aslam MA; Mahmood SU; Shahid M; Saeed A; Iqbal J
Eur J Med Chem; 2011 Nov; 46(11):5473-9. PubMed ID: 21981981
[TBL] [Abstract][Full Text] [Related]
20. Quinazolinones, Quinazolinthiones, and Quinazolinimines as Nitric Oxide Synthase Inhibitors: Synthetic Study and Biological Evaluation.
Camacho ME; Chayah M; García ME; Fernández-Sáez N; Arias F; Gallo MA; Carrión MD
Arch Pharm (Weinheim); 2016 Aug; 349(8):638-50. PubMed ID: 27328401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
